Tempsens Instruments IPO Sees 5.94 Times Subscription on Day 2 with GMP at 90%: Is It a Buy?

The Tempsens Instruments IPO has entered its second day of bidding and has garnered exceptional interest from investors. As of now, the offering is subscribed 5.94 times, with retail investors showing robust demand—6.46 times their reserved portion. The IPO aims to raise Rs 650 crore through a combination of a fresh issue and an offer for sale, with a price band set between Rs 285 and Rs 300 per share. The listing is anticipated on the NSE and BSE on August 28, 2026, following the allotment expected on August 25, 2026.

Investor sentiment in the grey market for this IPO appears to be very favorable, with the latest grey market premium (GMP) reported at Rs 270, equivalent to a 90% premium over the upper price range. If this sentiment holds, a strong listing price of approximately Rs 570 per share could be expected. However, it is important to note that grey market activities are unofficial and can fluctuate as the listing date approaches.

The successful subscription rates and significant GMP indicate that the IPO presents a potentially lucrative opportunity for retail investors looking to capitalize on strong listing gains. For those considering a long-term investment, the company’s solid financial performance, including a 19% growth in total income year-on-year, suggests a compelling case for investment. Although the IPO seems to be priced at a premium, the long-term prospects, characterized by the company’s diversified offerings and expanding international footprint, merit attention.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)